Dupilumab exposure and herpesvirus infection risk in atopic dermatitis: A claims‐based cohort study
0 citations
Abstract
The data that support the findings of this study were obtained under a contract with IQVIA Solutions Japan G.K. and are not publicly available. Data may be available from IQVIA Solutions Japan G.K. subject to applicable permissions, contractual restrictions, and privacy or ethical considerations.
// Source
View paper (DOI)OpenAlexJournal of the European Academy of Dermatology and VenereologyPublished 2026-09-17
Authors: K. Goto, Takahiro Itaya, Shinji Okabayashi, Yoshie Yamada, Yusuke Ogawa, Masaaki Isshiki, Kenji Kabashima, Yosuke Yamamoto
Institutions: Kyoto University, IQVIA (United Kingdom), IQ Solutions